View in EDS

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.

Saved in:
Bibliographic Details
Title: Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
Authors: Bromberg, Jacoline E C1 (AUTHOR) j.bromberg@erasmusmc.nl, Issa, Samar2 (AUTHOR), Bakunina, Katerina3 (AUTHOR), Minnema, Monique C4 (AUTHOR), Seute, Tatjana5 (AUTHOR), Durian, Marc6 (AUTHOR), Cull, Gavin7,8 (AUTHOR), Schouten, Harry C9 (AUTHOR), Stevens, Wendy B C10 (AUTHOR), Zijlstra, Josee M11 (AUTHOR), Baars, Joke W12 (AUTHOR), Nijland, Marcel13 (AUTHOR), Mason, Kylie D14 (AUTHOR), Beeker, Aart15 (AUTHOR), van den Bent, Martin J1 (AUTHOR), Beijert, Max16 (AUTHOR), Gonzales, Michael17 (AUTHOR), de Jong, Daphne18,19 (AUTHOR), Doorduijn, Jeanette K20 (AUTHOR)
Source: Lancet Oncology. Feb2019, Vol. 20 Issue 2, p216-228. 13p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 134423778
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Bromberg%2C+Jacoline+E+C%22">Bromberg, Jacoline E C</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> j.bromberg@erasmusmc.nl</i><br /><searchLink fieldCode="AR" term="%22Issa%2C+Samar%22">Issa, Samar</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bakunina%2C+Katerina%22">Bakunina, Katerina</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Minnema%2C+Monique+C%22">Minnema, Monique C</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Seute%2C+Tatjana%22">Seute, Tatjana</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Durian%2C+Marc%22">Durian, Marc</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cull%2C+Gavin%22">Cull, Gavin</searchLink><relatesTo>7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schouten%2C+Harry+C%22">Schouten, Harry C</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stevens%2C+Wendy+B+C%22">Stevens, Wendy B C</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zijlstra%2C+Josee+M%22">Zijlstra, Josee M</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baars%2C+Joke+W%22">Baars, Joke W</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nijland%2C+Marcel%22">Nijland, Marcel</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mason%2C+Kylie+D%22">Mason, Kylie D</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Beeker%2C+Aart%22">Beeker, Aart</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+den+Bent%2C+Martin+J%22">van den Bent, Martin J</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Beijert%2C+Max%22">Beijert, Max</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gonzales%2C+Michael%22">Gonzales, Michael</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Jong%2C+Daphne%22">de Jong, Daphne</searchLink><relatesTo>18,19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Doorduijn%2C+Jeanette+K%22">Doorduijn, Jeanette K</searchLink><relatesTo>20</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. Feb2019, Vol. 20 Issue 2, p216-228. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=134423778
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(18)30747-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 216
    Titles:
      – TitleFull: Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bromberg, Jacoline E C
      – PersonEntity:
          Name:
            NameFull: Issa, Samar
      – PersonEntity:
          Name:
            NameFull: Bakunina, Katerina
      – PersonEntity:
          Name:
            NameFull: Minnema, Monique C
      – PersonEntity:
          Name:
            NameFull: Seute, Tatjana
      – PersonEntity:
          Name:
            NameFull: Durian, Marc
      – PersonEntity:
          Name:
            NameFull: Cull, Gavin
      – PersonEntity:
          Name:
            NameFull: Schouten, Harry C
      – PersonEntity:
          Name:
            NameFull: Stevens, Wendy B C
      – PersonEntity:
          Name:
            NameFull: Zijlstra, Josee M
      – PersonEntity:
          Name:
            NameFull: Baars, Joke W
      – PersonEntity:
          Name:
            NameFull: Nijland, Marcel
      – PersonEntity:
          Name:
            NameFull: Mason, Kylie D
      – PersonEntity:
          Name:
            NameFull: Beeker, Aart
      – PersonEntity:
          Name:
            NameFull: van den Bent, Martin J
      – PersonEntity:
          Name:
            NameFull: Beijert, Max
      – PersonEntity:
          Name:
            NameFull: Gonzales, Michael
      – PersonEntity:
          Name:
            NameFull: de Jong, Daphne
      – PersonEntity:
          Name:
            NameFull: Doorduijn, Jeanette K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 14702045
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Lancet Oncology
              Type: main
ResultId 1